Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant

Liver Transplantation

Volumn 14, Issue 6, 2008, Pages 799-805

  Asensio, Angel ^a   Ramos, Antonio ^a   Cuervas Mons, Valentin ^a   Cordero, Elisa ^b   Sánchez Turrión, Victor ^a   Blanes, Marino ^b   Cervera, Carlos ^b   Gavalda, Joan ^b   Aguado, Jose M ^b   Torre Cisneros, Julian ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Grupo de Estudio de la Infección en el Trasplante GESITRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEPHALOSPORIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TACROLIMUS;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE DUCT RECONSTRUCTION; CHOLEDOCHOJEJUNOSTOMY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENTEROCOCCUS; ERYTHROCYTE TRANSFUSION; ESCHERICHIA COLI; FEMALE; GRAFT REJECTION; HEPATOJEJUNOSTOMY; HUMAN; INCIDENCE; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERITONITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SURGICAL TECHNIQUE; WOUND INFECTION;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 46049104887     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21435     Document Type: Article

References (32)

1. Sanchez-Bueno F, Cuende N, Matesanz R, Parrilla P. Emergency organ transplantation in Spain: liver emergency and outcomes. Transplant Proc 2005;37:3878-3880.
2. Briceno, J, Lopez-Cillero P, Fraga E, Pera C. Results of liver transplantation in a Spanish group: a report from the Cordoba unit. Clin Transpi 2001;15:187-194.
3. Cuervas-Mons V, Julio Martinez A, Dekker A, Starzl TE, Van Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology 1986;6:495-501.
4. Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001;33:S26-S31.
5. Patel R, Paya C. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997;10:86-124.
6. Singh N. Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis 1998;9:136-146.
7. RESITRA. Definitions of RESITRA. Available at: http://www.resitra.retics.net/web/index.asp.2004. Accessed December 2007.
8. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608.
9. Hosmer DV, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DV, ed. Applied 3 Logistic Regression. New York, NY: John Wiley & Sons; 1989:82-134.
10. Iinuma Y, Senda K, Fujihara N, Saito T, Takakura S, Kudo T, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004;78:704-709.
11. Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001;130:388
12. Arnow PM, Zachary KC, Thistlethwaite JR, Thompson KD, Bova JL, Newell KA. Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation 1998;65:1500-1503.
13. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995;21:1328.
14. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991;13:387.
15. Lumbreras CM, Lizasoin E, Moreno JM, Aguado R, Gomez I, Garcia I, et al. Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology 1992;39:362-365.
16. Losada I, Cuervas-Mons V, Millan I, Damaso D. Early infection in liver transplant recipients: incidence, severity, risk factors and antibiotic sensitivity of bacterial isolates. Enferm Infecc Microbiol Clin 2002;20:422-430.
17. Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996;61:1192-1197.
18. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrion VS, Barrios C, et al. Randomized trial of fluconazol versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 1996;174:583-588.
19. Grazi GL, Mazziotti A, Fisichella S, Scalzi E, Cavallari A. Antimicrobial prophylaxis with ceftriaxone for prevention of early postoperative infections after 49 liver transplantations. J Chemother 2000; 12(suppl 3):10-16.
20. Villacian JS, Paya CV. Prevention of infections in solid organ transplant recipients. Transpl Infect Dis 1999; 1: 50-64.
21. Whiting JF, Rossi SJ, Hanto DW. Infectious complications after OKT3 induction in liver transplantation. Liver Transpl Surg 1997;3:563-570.
22. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988;67:132-143.
23. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999;56:1839-1888.
24. Gridelli B, Panarello G, Salvatore G, Marcos A, Grossi P. Infections after living-donor liver transplantation. Surg Infect (Larchmt) 2006;(suppl 2):S105-S108.
25. Calleja Kempin JI, Banares R, Polo JR, Garcia Sabrido JL, Clemente G, Perez-Ferreiroa J, et al. Effect of antibiotic prophylaxis with vancomycin on methicillin-resistant Staphylococcus aureus infection following liver transplantation. Rev Esp Enferm. Dig 1993;84:42-25.
26. Krom RAF, Kingma LM, Haagsma Eb, Wesenhagen H, Slooff JH, Gips CH. Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery 1985;97:552-556.
27. Palomo Sanchez JC, Jimenez C, Moreno Gonzalez E, Garcia I, Palma F, Loinaz C, Gonzalez Ghamorro A. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998;45:1026-1033.
28. Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000;47:215-245.
29. Humar A, Ramcharan T, Denny R, Gillingham KJ, Payne WD, Matas AJ. Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation 2001;72:1920-1923.
30. Paterson DL, Singh N, Panebianco A, Wannstedt CF, Wagener MM, Gayowski T, Marino IR. Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. Transplantation 1998;66:593-598.
31. Bernabeu-Wittel M, Naranjo M, Cisneros JM, Canas E, Gentil MA, Algarra G, et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. Eur J Clin Microbiol Infect Dis 2002;21:173-180.
32. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis 1995;21:1077-1089.